Our Clinical Pipeline
Our Clinical Pipeline
Our Clinical Pipeline
The ASCEND Clinical Trial
The ASCEND Clinical Trial
The ASCEND Clinical Trial
U.S. FDA APPROVED PIVOTAL IDE TRIAL (Phase III)
U.S. FDA APPROVED PIVOTAL IDE TRIAL (Phase III)
U.S. FDA APPROVED PIVOTAL IDE TRIAL (Phase III)
TREATMENT OF PATIENTS WITH NON-HEALING DIABETIC FOOT ULCERS
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial
FDA IDE #: 27971; NTC 05095389
TREATMENT OF PATIENTS WITH NON-HEALING DIABETIC FOOT ULCERS
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial
FDA IDE #: 27971; NTC 05095389
TREATMENT OF PATIENTS WITH NON-HEALING DIABETIC FOOT ULCERS
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial
FDA IDE #: 27971; NTC 05095389
TRIAL DESIGN
TRIAL FLOWCHART
TRIAL DESIGN
TRIAL FLOWCHART
TRIAL DESIGN
TRIAL FLOWCHART
Twice the Healing in Half the Time
